WisdomTree BioRevolution Fund Rating $13.14 -0.12 (-0.91%) Closing price 06/13/2025 02:26 PM EasternExtended Trading$13.16 +0.02 (+0.14%) As of 06/13/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.69Holdings in WDNA have an aggregate rating of Moderate Buy based on 1,094 analyst ratings issued in the past year covering 81 companies (90.0% of the portfolio).WDNA Aggregate Price Target$13.14High Prediction$13.14Average Prediction$13.14Low Prediction$13.14Holdings in WDNA have an aggregate price target of $13.14 and a range of $13.14 to $13.14 covering 81 companies (90.0% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy19 Buy rating(s)Moderate Buy38 Moderate Buy rating(s)Hold22 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell1 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 81 WDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.69%NTRANatera$165.34+0.6%1.8536 of 5 stars3.00$184.63 11.7%15Positive NewsInsider Trade2.39%VERVVerve Therapeutics$6.16-2.5%2.2794 of 5 stars3.00$25.75 318.0%6Gap Down2.29%LLYEli Lilly and Company$818.56+0.8%4.8357 of 5 stars2.76$1,011.37 23.6%21Trending NewsAnalyst Revision2.15%RGNXREGENXBIO$9.27-9.1%4.28 of 5 stars2.83$31.63 241.2%6Gap Down2.10%CRSPCRISPR Therapeutics$41.36+0.2%3.2938 of 5 stars2.50$71.75 73.5%18Analyst RevisionGap Down2.06%AGIOAgios Pharmaceuticals$34.30-0.6%3.9332 of 5 stars2.71$58.60 70.8%7Analyst Revision2.04%GILDGilead Sciences$109.98-1.8%4.9069 of 5 stars2.78$110.55 0.5%27Trending NewsOptions VolumeAnalyst Revision2.00%NTLAIntellia Therapeutics$8.31-0.5%4.6538 of 5 stars2.67$34.95 320.6%21Analyst RevisionGap Up1.96%TWSTTwist Bioscience$33.52-0.3%4.1073 of 5 stars2.70$50.40 50.4%10Gap Down1.93%UTHRUnited Therapeutics$283.35-1.0%4.9913 of 5 stars2.69$393.08 38.7%13Positive NewsAnalyst ForecastInsider TradeAnalyst Revision1.86%DNAGinkgo Bioworks$8.94-3.8%0.6043 of 5 stars1.67$5.77 -35.5%3Gap Down1.83%VRTXVertex Pharmaceuticals$455.45-1.0%4.6304 of 5 stars2.57$515.04 13.1%30News CoveragePositive NewsAnalyst Revision1.83%VCYTVeracyte$26.44-0.9%4.0764 of 5 stars2.70$40.90 54.7%10Analyst Upgrade1.78%BEAMBeam Therapeutics$17.06-2.2%3.0804 of 5 stars3.00$48.75 185.8%15Analyst RevisionGap Down1.77%ARCTArcturus Therapeutics$12.38-2.1%3.2114 of 5 stars3.11$53.50 332.1%9Positive NewsAnalyst RevisionGap Down1.76%MRNAModerna$26.67-2.5%4.4488 of 5 stars2.04$46.61 74.8%23Trending NewsOptions VolumeGap Down1.69%BNTXBioNTech$106.57+1.6%2.8484 of 5 stars2.83$138.25 29.7%18Trending News1.65%AMGNAmgen$295.22-0.7%4.4515 of 5 stars2.38$309.22 4.7%24News CoveragePositive NewsAnalyst Revision1.59%TXG10x Genomics$10.41-1.6%4.2255 of 5 stars2.38$15.81 51.9%16Analyst ForecastGap Down1.58%SANASana Biotechnology$2.59+2.0%1.9409 of 5 stars2.86$10.80 317.0%7Positive NewsGap Up1.57%CTVACorteva$72.36-0.2%4.2269 of 5 stars2.80$70.92 -2.0%15Positive News1.46%AZNAstraZeneca$74.42-0.8%2.8684 of 5 stars3.13$85.00 14.2%8Positive NewsAnalyst Revision1.43%GPCRStructure Therapeutics$21.68-2.4%2.2596 of 5 stars3.00$76.50 252.9%7News CoverageAnalyst RevisionGap Down1.37%BMRNBioMarin Pharmaceutical$56.22-1.9%4.9346 of 5 stars2.74$93.45 66.2%23Positive NewsAnalyst Revision1.36%TEMTempus AI$71.220.0%1.6555 of 5 stars2.54$63.42 -11.0%13Trending NewsInsider TradeGap Down1.34%EDITEditas Medicine$1.97-9.6%4.2262 of 5 stars2.29$5.36 172.3%14Positive NewsAnalyst RevisionGap Down1.30%JNJJohnson & Johnson$156.90+0.2%4.7636 of 5 stars2.55$170.88 8.9%20Trending News1.29%TECHBio-Techne$50.52-2.0%4.8531 of 5 stars2.45$72.00 42.5%111.28%ZTSZoetis$164.27-2.7%4.6438 of 5 stars3.10$212.75 29.5%10Positive NewsGap Down1.26%BMYBristol-Myers Squibb$49.71-1.9%4.8036 of 5 stars2.32$58.00 16.7%22Positive NewsAnalyst Revision1.26%IONSIonis Pharmaceuticals$35.59-0.1%4.3696 of 5 stars2.68$57.59 61.8%19News CoverageAnalyst Forecast1.24%FOLDAmicus Therapeutics$6.03-2.3%4.0233 of 5 stars2.70$16.22 169.0%101.24%QUREuniQure$15.34-4.1%2.0689 of 5 stars2.91$37.82 146.5%11Analyst DowngradeAnalyst RevisionGap Down1.21%RAREUltragenyx Pharmaceutical$37.49-4.6%4.412 of 5 stars2.92$88.77 136.8%13Positive NewsAnalyst RevisionGap Down1.19%EXASExact Sciences$53.52-0.9%4.6 of 5 stars2.95$70.90 32.5%22News CoveragePositive News1.19%DHRDanaher$200.51-2.2%4.8123 of 5 stars2.80$248.17 23.8%20Positive News1.14%DARDarling Ingredients$35.99+9.1%4.2018 of 5 stars2.88$46.00 27.8%8Positive NewsOptions VolumeHigh Trading Volume1.12%GERNGeron$1.51-3.2%3.1484 of 5 stars2.78$5.06 235.3%91.10%GMABGenmab A/S$22.82-1.2%3.8256 of 5 stars2.69$39.17 71.6%13Analyst Downgrade1.07%STOKStoke Therapeutics$11.53-2.5%3.6425 of 5 stars3.29$23.20 101.2%7Analyst Revision1.07%ABSIAbsci$2.78-2.1%2.0988 of 5 stars3.00$8.40 202.2%51.05%IMNMImmunome$9.20-6.0%1.6177 of 5 stars3.00$23.33 153.6%6News CoveragePositive NewsGap Up1.04%PFEPfizer$24.51-1.3%4.9738 of 5 stars2.53$29.17 19.0%15Trending NewsAnalyst Revision1.04%RGENRepligen$127.52-2.9%4.7259 of 5 stars2.64$173.25 35.9%14Gap Down1.01%SWTXSpringWorks Therapeutics$46.78+0.0%1.5496 of 5 stars2.13$52.57 12.4%8Positive News1.00%ARGXargenx$577.89-1.5%3.487 of 5 stars3.05$709.18 22.7%22Analyst Forecast1.00%SDGRSchrödinger$21.43-6.1%2.4804 of 5 stars3.00$32.80 53.1%60.99%SRPTSarepta Therapeutics$36.18-3.0%4.7004 of 5 stars2.87$122.61 238.9%230.94%REGNRegeneron Pharmaceuticals$529.24+1.4%4.8808 of 5 stars2.85$836.48 58.1%26Positive NewsAnalyst Revision0.91%EXELExelixis$41.59-0.5%4.3824 of 5 stars2.47$39.76 -4.4%19Analyst Forecast0.89%ALLOAllogene Therapeutics$1.34-4.3%3.8371 of 5 stars2.90$8.44 530.2%10Positive NewsGap Down0.86%ROIVRoivant Sciences$11.32-1.3%2.2269 of 5 stars3.00$17.50 54.6%40.74%BIOBio-Rad Laboratories$227.43-2.1%4.7499 of 5 stars2.75$324.25 42.6%4Analyst Revision0.71%HALOHalozyme Therapeutics$53.98-1.0%4.8749 of 5 stars2.17$61.90 14.7%12Positive News0.70%FATEFate Therapeutics$1.28-8.9%4.0809 of 5 stars2.22$4.14 224.9%9News CoverageAnalyst ForecastAnalyst Revision0.69%RXRXRecursion Pharmaceuticals$4.92-4.8%1.9277 of 5 stars2.33$7.60 54.5%6Analyst RevisionGap UpHigh Trading Volume0.69%NEONeoGenomics$7.07-4.3%3.7925 of 5 stars2.45$13.83 95.7%11News CoverageGap Down0.68%BIIBBiogen$130.65-1.3%4.7258 of 5 stars2.38$188.19 44.0%32Trending NewsAnalyst Forecast0.67%MRKMerck & Co., Inc.$81.68-0.2%4.9956 of 5 stars2.43$109.19 33.7%21Positive NewsAnalyst Revision0.65%ACLXArcellx$66.00-0.8%2.7899 of 5 stars3.07$111.33 68.7%14Positive NewsInsider TradeAnalyst RevisionGap Down0.61%FMCFMC$41.44-4.3%3.369 of 5 stars2.21$49.46 19.4%14Analyst Upgrade0.58%KRYSKrystal Biotech$137.07-2.3%4.4769 of 5 stars3.00$211.13 54.0%9Positive NewsAnalyst Revision0.57%IOVAIovance Biotherapeutics$2.24-3.0%4.6356 of 5 stars2.50$13.30 493.8%12Trending NewsGap Down0.52%MYGNMyriad Genetics$5.03-3.1%4.1879 of 5 stars2.13$14.38 186.0%160.51%CVACCureVac$5.57-0.5%4.2702 of 5 stars2.67$9.00 61.6%3Trending NewsAnalyst ForecastOptions VolumeGap DownHigh Trading Volume0.48%ARWRArrowhead Pharmaceuticals$15.74-3.0%3.7033 of 5 stars2.75$43.71 177.7%8Positive NewsAnalyst UpgradeAnalyst RevisionGap Down0.45%ALNYAlnylam Pharmaceuticals$307.99+1.1%4.246 of 5 stars2.77$319.58 3.8%26Positive NewsAnalyst Forecast0.43%BPMCBlueprint Medicines$127.96-0.2%1.1974 of 5 stars2.32$129.35 1.1%22Positive NewsHigh Trading Volume0.39%RVMDRevolution Medicines$40.59-1.3%4.4147 of 5 stars3.00$67.08 65.3%12Positive News0.38%RCKTRocket Pharmaceuticals$2.93-4.6%4.9455 of 5 stars2.41$19.57 568.0%17Trending NewsAnalyst Revision0.38%ILMNIllumina$86.93-1.4%4.904 of 5 stars2.47$126.94 46.0%19Positive NewsAnalyst ForecastOptions Volume0.37%QGENQiagen$47.08-0.7%3.3176 of 5 stars2.30$48.42 2.8%100.36%BBIOBridgeBio Pharma$39.78+0.3%4.6133 of 5 stars2.92$57.36 44.2%12Insider TradeAnalyst Revision0.34%VCELVericel$42.67+0.4%2.4662 of 5 stars3.00$61.14 43.3%7Positive News0.33%BHVNBiohaven$15.43-1.1%3.0049 of 5 stars3.07$59.46 285.5%15Short Interest ↑Analyst Revision0.33%TMOThermo Fisher Scientific$402.12-3.2%4.9702 of 5 stars2.80$605.30 50.5%20Trending News0.29%TSNTyson Foods$54.75-1.7%4.6976 of 5 stars2.10$62.63 14.4%10News CoveragePositive News0.29%CRBUCaribou Biosciences$1.11-4.3%2.8845 of 5 stars3.00$8.50 665.8%4News CoveragePositive NewsAnalyst DowngradeAnalyst Revision0.27%PACBPacific Biosciences of California$1.20+1.7%2.0496 of 5 stars2.50$2.13 77.6%8Positive News0.20%ORGNOrigin Materials$0.42-4.3%2.5658 of 5 stars1.00$1.50 256.0%1Positive NewsGap Down0.18%GPREGreen Plains$5.58+20.0%3.0982 of 5 stars2.25$11.93 113.8%8Positive NewsGap UpHigh Trading Volume This page (BATS:WDNA) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.